| Literature DB >> 28344221 |
R A González-Fuenzalida1, Y Moliner-Martínez2, Helena Prima-Garcia3, Antonio Ribera4, P Campins-Falcó5, Ramon J Zaragozá6.
Abstract
The use of magnetic nanomaterials for analytical applications has increased in the recent years. In particular, magnetic nanomaterials have shown great potential as adsorbent phase in several extraction procedures due to the significant advantages over the conventional methods. In the present work, the influence of magnetic forces over the extraction efficiency of triazines using superparamagnetic silica nanoparticles (NPs) in magnetic in tube solid phase microextraction (Magnetic-IT-SPME) coupled to CapLC has been evaluated. Atrazine, terbutylazine and simazine has been selected as target analytes. The superparamagnetic silica nanomaterial (SiO₂-Fe₃O₄) deposited onto the surface of a capillary column gave rise to a magnetic extraction phase for IT-SPME that provided a enhancemment of the extraction efficiency for triazines. This improvement is based on two phenomena, the superparamegnetic behavior of Fe₃O₄ NPs and the diamagnetic repulsions that take place in a microfluidic device such a capillary column. A systematic study of analytes adsorption and desorption was conducted as function of the magnetic field and the relationship with triazines magnetic susceptibility. The positive influence of magnetism on the extraction procedure was demonstrated. The analytical characteristics of the optimized procedure were established and the method was applied to the determination of the target analytes in water samples with satisfactory results. When coupling Magnetic-IT-SPME with CapLC, improved adsorption efficiencies (60%-63%) were achieved compared with conventional adsorption materials (0.8%-3%).Entities:
Keywords: environmental samples; magnetic nanoparticles; magnetic susceptibility; on-line solid phase microextraction; triazines
Year: 2014 PMID: 28344221 PMCID: PMC5304668 DOI: 10.3390/nano4020242
Source DB: PubMed Journal: Nanomaterials (Basel) ISSN: 2079-4991 Impact factor: 5.076
Figure 1(a) Frequency dependence of AC susceptibility of the NPs vs. Temperature with amplitude of 17 Oe; (b) Arrhenius law fit for the nanoparticles.
B3LYP/6-31G** total energies (E, au) in vacuo and in water.
| Compound | In vacuo | In H2O |
|---|---|---|
| Acetylsalicilic acid | −648.709453 | −648.720605 |
| Acetaminophen | −515.494917 | −515.507984 |
| Diclofenac | −1665.736440 | −1665.748421 |
| Ibuprofen | −656.734267 | −656.741794 |
| Atenolol | −881.951314 | −881.969818 |
| Chlorpyrifos | −2671.570830 | −2671.582537 |
| Chlorfenvinphos | −2409.975077 | −2409.986882 |
| Simazine | −1007.990723 | −1008.000696 |
| Atrazine | −1047.309710 | −1047.319747 |
| Terbutylazina | −1086.624906 | −1086.633924 |
Isotropic diamagnetic susceptibility (IDS), isotropic paramagnetic susceptibility (IPS) and isotropic total susceptibility (ITS) a in au.
| Compound | In vacuo | In H2O | ||||
|---|---|---|---|---|---|---|
| IDS | IPS | ITS | IDS | IPS | ITS | |
| Acetylsalicilic acid | −375.1256 | 354.4428 | −20.6827 | −376.0739 | 355.3678 | −20.7061 |
| Acetaminophen | −361.7369 | 342.8417 | −18.8952 | −361.2246 | 342.2788 | −18.9458 |
| Diclofenac | −1073.6967 | 1037.0720 | −36.6247 | −1071.6524 | 1035.0105 | −36.6419 |
| Ibuprofen | −784.5031 | 754.6211 | −29.8820 | −784.0887 | 754.2092 | −29.8795 |
| Atenolol | −1895.5223 | 1858.5274 | −36.9949 | −1905.1243 | 1868.0617 | −37.0626 |
| Chlorpyrifos | −1070.6714 | 1033.9535 | −36.7179 | −1070.5282 | 1033.7223 | −36.8059 |
| Chlorfenvinphos | −1254.5588 | 1216.6838 | −37.8751 | −1257.4740 | 1219.5444 | −37.9296 |
| Simazine | −588.8682 | 563.8451 | −25.0230 | −591.2717 | 566.3096 | −24.9621 |
| Atrazine | −716.3337 | 688.7578 | −27.5760 | −717.3796 | 689.8408 | −27.5388 |
| Terbutylazine | −787.0130 | 757.0138 | −29.9993 | −786.0579 | 756.1178 | −29.9401 |
a ITS = IDS + IPS.
Figure 5Schematic diagram of the Magnetic-IT-SPME-Cap-LC system. (---) adsorption (load position of the injection valve); and () desorption (injection position of the injection valve).
Figure 2Variation of the extraction efficiency as function of the magnetic field for (1) simazine; (2) atrazine; and (3) terbutylazine. Injection 100 μL of a mixture of the target analytes (30 μg L−1). Mobile phase: methanol:water 85:15, flow 6 μL min−1. Badsorption = Bdesorption (reverse polarity).
Figure 3Chromatogram obtained with the magnetic capillary column in the Magnetic-IT-SPME device coupled with Cap-LC-DAD (230 nm); (1) simazine; (2) atrazine; and (3) terbutylazine. (a) Applying magnetic field Badsoprtion = 150 G (Bdesorption = 150 G, reverse polarity); (b) Without magnetic field (B = 0 G). Injection 100 μL of a mixture of the target analytes (30 μg L−1). Mobile phase: methanol:water 85:15, flow 6 μL min−1.
Figure 4Comparison of the extraction efficiency (%) for simazine, atrazine and terbutylazine with a TRB-5 commercial capillary column, SiO2 supported Fe3O4 capillary column without magnetic field (B = 0 G) and with the SiO2 supported Fe3O4 capillary column applying magnetic field (Badsorption = 150 G, Bdesorption = 150 G, reverse polarity).
Detection limit (LOD), quantification limit (LOQ) and relative standard deviation (RSD) for simazine, atrazine and terbutylazine achieved with Magnetic-IT-SPME-CapLC-DAD.
| Compound | LOD (μg L−1) | LOQ (μg L−1) | RSD (%) |
|---|---|---|---|
| Simazine | 0.4 | 1.4 | 10 |
| Atrazine | 0.3 | 1.1 | 9 |
| Terbutylazine | 0.3 | 1.0 | 7 |